scispace - formally typeset
I

Inés Mármol

Researcher at University of Zaragoza

Publications -  17
Citations -  1228

Inés Mármol is an academic researcher from University of Zaragoza. The author has contributed to research in topics: Thioredoxin reductase & Medicine. The author has an hindex of 10, co-authored 14 publications receiving 720 citations.

Papers
More filters
Journal ArticleDOI

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

TL;DR: The choice of first-line treatment in CRC follows a multimodal approach based on tumour-related characteristics and usually comprises surgical resection followed by chemotherapy combined with monoclonal antibodies or proteins against vascular endothelial growth factor (VEGF) and epidermal growth receptor (EGFR).
Journal ArticleDOI

Therapeutic Applications of Rose Hips from Different Rosa Species.

TL;DR: The role of different species of Rosa in the prevention of treatment of various disorders related to oxidative stress, is examined, focusing on new therapeutic approaches from a molecular point of view.
Journal ArticleDOI

Alkynyl gold(I) complex triggers necroptosis via ROS generation in colorectal carcinoma cells

TL;DR: The obtained data show that gold complexes might have the ability of inducing necroptosis, and that the synthesized compound [Au(CC-2-NC5H4)(PTA)] is an interesting alternative to current chemotherapy drugs in cases of apoptosis resistance.
Journal ArticleDOI

Insight into the potential application of polyphenol-rich dietary intervention in degenerative disease management

TL;DR: The present review highlights the potential effect of dietary intervention with polyphenol-rich food and plant extracts in patients with cancer, diabetes and neurodegenerative, autoimmune, cardiovascular and ophthalmic diseases, as well as the possible molecular mechanisms of action suggested in numerous studies with animal models.
Journal ArticleDOI

A systematic review of the potential uses of pine bark in food industry and health care

TL;DR: Both in vitro and in vivo assays suggest a promising future for pine as an adjuvant therapy and the potential of pine bark extract as a source of antioxidant and treatment diseases.